Details for New Drug Application (NDA): 215435
✉ Email this page to a colleague
The generic ingredient in RAMELTEON is ramelteon. There are three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ramelteon profile page.
Summary for 215435
Tradename: | RAMELTEON |
Applicant: | Innogenix |
Ingredient: | ramelteon |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 215435
Mechanism of Action | Melatonin Receptor Agonists |
Suppliers and Packaging for NDA: 215435
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
RAMELTEON | ramelteon | TABLET;ORAL | 215435 | ANDA | Westminster Pharmaceuticals, LLC | 69367-356 | 69367-356-01 | 100 TABLET, COATED in 1 BOTTLE (69367-356-01) |
RAMELTEON | ramelteon | TABLET;ORAL | 215435 | ANDA | Westminster Pharmaceuticals, LLC | 69367-356 | 69367-356-30 | 30 TABLET, COATED in 1 BOTTLE (69367-356-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 8MG | ||||
Approval Date: | Aug 24, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription